Eileen O'Reilly, M.D.

 
Assistant Professor of Medicine
Cornell University Medical College
Associate Faculty Member
Memorial Sloan-Kettering Cancer Center
Education 

M.D., University of Dublin Trinity College School of Medicine, Dublin, Ireland, 1990

Residency 

Internal Medicine, Saint Vincent's Hospital, Dublin, Ireland

Fellowship 

Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York

Certifications 

Internal Medicine (Ireland)

Hospital Affiliations/Admitting Privileges 

Memorial Sloan-Kettering Cancer Center

NewYork-Presbyterian Hospital

 
Dr. O’Reilly is a leading authority in the clinical study and treatment of pancreatic cancer at Memorial Sloan-Kettering Cancer Center where she is a member of the Gastrointestinal Oncology Service. Her expertise includes esophageal cancer, gastric cancer, pancreatic, hepatobiliary, colorectal cancers, and unknown primary tumors.  Dr. O'Reilly's primary clinical interests include the development of new treatment and therapies against pancreatic cancer. She is currently the principal investigator for six clinical trials, testing treatments against resectable and unresectable pancreatic cancer. She has published over 30 articles in peer-reviewed journals including Gastrointestinal Cancer Research, Pancreatology, and Cancer Gene Therapy. Dr. O'Reilly also co-authored the book "100 Questions and Answers About Pancreatic Cancer." Dr. O'Reilly was recognized among Castle Connolly's 'America's Top Doctors' from 2006 to 2009 and 'America's Top Doctors for Cancer' from 2005 to 2007.
 
As an assistant professor of medicine at Cornell University Medical College, Dr. O'Reilly is active in instructing medical students and residents in medical oncology. She has lectured at national conferences for pancreatic and gastrointestinal cancer. She was also an invited speaker at the World Congress on Gastrointestinal Cancer held in Spain in the summer of 2009. Dr. O'Reilly serves on several committees at Memorial Sloan-Kettering Cancer Center including being involved in their Institutional Review Board and Research and Clinical Council Committee. Dr. O'Reilly serves on the Science Board for the Lorenzen Cancer Foundation and is a member of the American Society of Clinical Oncology.